Ar
Non verificato

Arcturus Therapeutics Holdings Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaHIV, AIDS e malattie autoimmuniMedicina - VarieSalute
05/03/2026
Eventi
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Sanità
Salute
Farmaceutica
Arcturus Therapeutics to Attend Upcoming Investor Conference
1.00
03/03/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Farmaceutica
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress
1.00
17/02/2026
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026
1.00
08/01/2026
Salute
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Eventi
Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
1.00
24/11/2025
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Eventi
Arcturus Therapeutics to Attend Upcoming Investor Conference
1.00
10/11/2025
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Farmaceutica
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
1.00
04/11/2025
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Eventi
Arcturus Therapeutics to Attend Upcoming Investor Conferences
1.00
28/10/2025
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025
1.00
22/10/2025
Biotecnologia
Igiene alimentare
Salute
Sanità
Farmaceutica
Scienza
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Industria
Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program
1.00
26/08/2025
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Eventi
Arcturus Therapeutics to Attend Upcoming Investor Conferences
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0